CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection Science For The Real World: Canadian Hematology Today 24/09/2025 24 min Temporada 1 Episodio 3 Listen "CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection" Reproducir Descargar episodio Ver en sitio original Episode Synopsis Sponsored by Bristol Myers Squibb. Hosted on Acast. See acast.com/privacy for more information. More episodes of the podcast Science For The Real World: Canadian Hematology Today Prise en charge des patients atteints de LLC doublement exposée et réfractaire. 18/11/2025 Addressing the management of patients with double exposed and refractory CLL 18/11/2025 Practical considerations in the management of early rrMM in the Canadian context 06/01/2025 The role of selinexor in early rrMM and sequencing in 2024. 26/06/2024 Ver todos los episodios Share Facebook Twitter LinkedIn